Fishawack Health announces today that it is unifying under the new name and brand, Avalere Health. Avalere Health is purposefully built to be the leading, global commercialization partner for changemaking healthcare companies looking to maximize the value of their portfolios while connecting patients to life-changing health solutions.
Linqia introduces a first-to-market offering designed to make it safer and easier for pharmaceutical brands (OTC and Rx) to leverage professional healthcare professionals for influencer marketing campaigns.
“Separately, Wunderman Thompson and VMLY&R are two of WPP’s strongest and best-performing agencies. Together, they will deliver an even wider, fully integrated suite of capabilities to our clients in every market. Marketers today expect seamless links between their brand advertising and technology solutions and platforms,” said WPP CEO Mark Read. “VML provides an immediate solution to this business imperative.”
The company’s new integrated solution helps emerging biotech companies ‘nail the narrative’ when it comes to securing investment capital, talent and clinical trial participants.
These are exciting times for U.S. health care: market access disruption is upon us. It’s great news for patients – and with an informed approach to access strategies, it could be great news for pharma brands, too.
“Curtis is a former payer who is invaluable to the strategic arm of our business, integral to the high quality of work we deliver, and a voice that our clients and employees respect,” said John Guarino, president and managing partner of Peregrine Market Access. “Promoting Curtis to the highest level of leadership at the company reflects his indispensable role and my confidence in him to help take our company to the next level.”
Healthware will immediately merge with EVERSANA INTOUCH, shifting from long-standing partnership to a full-service global, award-winning agency network.
Pharma companies are striving to convey the true impact of diseases on patients while continuing to empower them.
We see pharma marketers turn to television and digital, but how can they make sure ads are seen, targeted to relevant audiences, and actually driving results?
Omnicom Chairman and CEO John Wren announced the elevation of Alex Lubar as Global CEO of DDB Worldwide. Lubar succeeds current Global CEO Marty O’Halloran who will continue as Chairman. In addition, Glen Lomas currently CEO, DDB EMEA, based in London, becomes Global President and Chief Operating Officer in partnership with Lubar.
